Extract to table
Pull the structured facts out of a document: parties, dates, amounts, obligations.
Extract to table / letter-to-irs-response-to-nopa-20231025.docx
letter-to-irs-response-to-nopa-20231025.docx
Parties
HARKNESS LLP
Penterra Pharmaceuticals Corp
Associates LLP
Ireland Inc
Whitmore Valuation Group LLC
Global Tax Penterra Pharmaceuticals Corp
General Counsel Penterra Pharmaceuticals Corp
Dates
October 25, 2023
October 12, 2023
June 8, 2022
June 2, 2022
October 14, 2023
July 1, 2012
August 15, 2022
December 22, 2023
December 31, 2024
Amounts
$42,650,000
$235,010,000
$188,032,000
$380,392,000
$380.40
$380,400,000
$79,884,000
$15,976,800
$312,000,000
€47.2
Obligations
Nothing in this letter, or in any prior or future communication by or on behalf of PPC, shall be construed as a concession, waiver, or abandonment of any position, right, defense, or argument available to PPC
PPC's decision not to address any particular issue or argument in this initial response letter does not indicate agreement with the IRS's position on that issue and shall not be deemed an admission or concession of any kind